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Abstract
Puumala hantavirus (PUUV) infection, also known as nephropathia epidemica, is the most common cause of hemorrhagic
fever with renal syndrome (HFRS) in Europe. The pathogenesis of PUUV nephropathia epidemica is complex and
multifactorial, and the risk factors for severe acute kidney injury (AKI) during acute PUUV infection are not well defined. We
conducted a prospective study of hospitalized patients with PUUV infection in Tampere, Finland to identify acute illness risk
factors for HFRS severity. Serial daily blood and urine samples were collected throughout acute illness and at 2 week and 6
month convalescent visits. By univariate analyses, the maximum white blood cell count during acute illness was a risk factor
for severe AKI. There were no significant associations between PUUV-induced AKI severity and platelet counts, C-reactive
protein, or alanine aminotransferase levels. Maximum plasma interleukin (IL)-6, urine IL-6, and urine IL-8 concentrations
were positively associated with PUUV-induced AKI. Finally, the maximum urinary sediment GATA-3 mRNA level was
positively correlated with the peak fold-change in serum creatinine, regardless of AKI severity classification. By multivariate
analyses, we found that the maximum levels of leukocytes and urinary sediment GATA-3 mRNA during acute illness were
independent risk factors for severe PUUV-induced AKI. We have identified novel acute illness risk factors for severe PUUV-
induced AKI.
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Introduction
Puumala hantavirus (PUUV) infection, also known as nephro-
pathia epidemica (NE), is the most common cause of hemorrhagic
fever with renal syndrome (HFRS) in Europe [1]. In Finland, the
average annual incidence is 31/100,000 population and the
incidence is increasing [2]. The course of the disease may be
divided into febrile, hypotensive, oliguric, diuretic, and convales-
cent phases, but these phases may overlap and the clinical severity
varies. Renal involvement results in the need for transient
hemodialysis treatment in 5% of hospital-treated NE patients
[1], and the case fatality rate is 0.08% [2].
The pathogenesis of PUUV NE is complex and multifactorial
with host genetic properties having an impact on disease severity.
Human leukocyte alloantigen (HLA) B8 and DRB1*0301 alleles
are associated with severe clinical disease, and genetic polymor-
phisms of the cytokines tumor necrosis factor alpha, interleukin-1
(IL-1), and interleukin-1 receptor antagonist (IL-1Ra) also
influence the outcome of infection [3,4]. The surface density of
platelet b3 integrin, the cellular receptor of hantaviruses, is
associated with disease severity in patients infected with Hantaan
virus [5], another HFRS inducing hantavirus. However, the risk
factors for severe acute kidney injury (AKI) during acute PUUV
HFRS are less well defined. Two reports have found that serum
and urine levels of interleukin-6 (IL-6) correlated with PUUV
HFRS severity [6,7]. Another report has shown that high serum
indoleamine 2,3-dioxygenase activity was associated with severe
AKI in PUUV NE [8]. We conducted a prospective study of
hospitalized patients with PUUV infection in Tampere, Finland to
identify acute illness risk factors for HFRS severity. Serial daily
blood and urine samples were collected throughout acute illness
and at 2 week and 6 month convalescent visits. We found that the
maximum levels of leukocytes and urinary sediment GATA-3
mRNA [9] during acute illness were independent risk factors for
severe PUUV-induced AKI.
Methods
Ethics Statement
The Institutional Review Boards of Tampere University
Hospital and the University of Massachusetts Medical School
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35402approved the study. The study was conducted according to the
principles expressed in the Declaration of Helsinki. Patients were
recruited and enrolled after providing written informed consent.
Clinical Study
The study was carried out at Tampere University Hospital,
University of Tampere School of Medicine, Tampere, Finland. All
patients came from the Pirkanmaa region of Finland and were
hospitalized at Tampere University Hospital due to serologically
confirmed acute PUUV infection between 2005–2007. Acute
PUUV infection was diagnosed on presentation by a positive rapid
anti-PUUV IgM test (POCH PUUMALA IgM, Reagena Ltd,
Toivala, Finland) and later confirmed by an anti-PUUV IgM EIA
(Reagena Ltd, Toivala, Finland). Severe AKI during PUUV
infection was defined by a .3-fold rise in serum creatinine (Cr)
during acute illness compared to a 6 month baseline value (Acute
Kidney Injury Network (AKIN) stage 3 [10]).
Clinical variables and laboratory data were obtained daily
throughout hospitalization and were abstracted onto a standard-
ized case report form. The clinical variables included the length of
hospital stay (days), length of fever (days), history of smoking, need
for transient hemodialysis treatment (yes/no), systolic and diastolic
blood pressures (mmHg), heart rate, respiratory rate, daily urinary
output (ml), and daily weight (kg). Daily complete blood counts
(CBC), plasma CRP levels, serum liver function tests, and serum
Cr concentrations were determined at the Laboratory Centre of
the Pirkanmaa Hospital District using standard methods. Daily
urine Cr and albumin concentrations were determined at the
University of Massachusetts Memorial HealthCare Hospital Labs
using standard methods. Serial daily morning blood (plasma) and
urine were collected and cryopreserved for 5 consecutive days or
until the end of hospitalization, whichever came first. Blood and
urine samples were also collected at 1565 days and 180614 days
after hospitalization. The urine was spun at 500 g65 minutes, and
cell free urine was cryopreserved. Urinary cell sediment was placed
immediately in RNALater
TM and cryopreserved.
Luminex
TM analysis
Serial daily plasma and urine analyte concentrations were
determined on a Bio-Plex Luminex-100 station at the Baylor
NIAID Luminex Core Facility (Dallas, TX) by standard methods.
Eight cytokines and chemokines were selected as analytes to
examine in plasma and urine over the course of acute PUUV
infection: IL-1a, IL-1b, IL-2, IL-6, IL-8, IL-15, CXCL10, and
MCP-1. R&D Systems (Minneapolis, MN) Luminex
TM reagents
were used. An eight point standard curve was run for each analyte,
and all analyte concentrations fell on the standard curves.
Quantitative (q)RT-PCR
Total cellular RNA from urinary sediment was isolated using
the RNeasy Kit (Qiagen, Valencia, CA). Urine cellular RNA was
pre-amplified using the TaqmanH PreAmp Master Mix and
probes, per the manufacturer’s instructions (Applied Biosystems,
Foster City, CA). The selected genes were amplified with similar
efficiency. qRT-PCR for a T-cell associated gene, CD3 epsilon
(CD3e), a type 1 cytokine transcription factor (T-bet), a type 2
cytokine transcription factor (GATA-3), and the housekeeping
gene b-actin was performed on an ABI 7300 real-time PCR
machine, using TaqmanH reagents and a standard protocol
(Applied Biosystems, Foster City, CA). Each mRNA transcript in
each sample was assayed in triplicate. The relative expression of
CD3e, T-bet, and GATA-3 mRNA levels was normalized to the
b-actin mRNA level in each sample. Fold-changes in normalized
CD3e, T-bet, and GATA-3 mRNA levels were expressed relative
to 2 week convalescent values in each patient using the 2
2DDCt
method.
Statistical Analysis
The PASW software package (version 18.0) was used for
statistical analyses. For normally distributed variables, compari-
sons between 2 groups were analyzed using Student’s t test.
Pearson’s correlation between two normally distributed variables
was determined. For non-normally distributed variables, compar-
isons between 2 groups were analyzed using the Mann-Whitney U
test. Spearman’s correlation between two non-normally distribut-
ed variables was determined. The Spearman r value and 95%
confidence interval (CI) are shown. A binary logistic regression
model and a linear regression model of log10 transformed variables
were constructed. P,0.05 was considered significant;
0.05#p,0.10 was considered a significant trend. Values are
presented as the median [95% CI of the median].
Results
Study Subject Characteristics
We enrolled 36 consecutive PUUV-infected patients who
presented to Tampere University Hospital in prospective fashion.
Serial daily blood and urine samples were collected in all study
subjects throughout their hospital course, and at convalescent visits
2 weeks and 6 months after hospitalization. 15 patients (42%)
developed severe AKI; two patients required hemodialysis
support, and all patients recovered from their PUUV infection
without serious sequelae.
There were no significant differences in the baseline character-
istics and days of fever at clinical presentation between the patients
with severe AKI and those with non-severe AKI (Table 1). The
peak fold-change in serum Cr was 7.6 [5.4–9.7] among the
patients with severe PUUV-induced AKI and 1.7 [1.4–2.0] among
the patients with non-severe PUUV-induced AKI. Among the
patients with severe PUUV-induced AKI, serum Cr levels typically
peaked 8–10 days after illness onset whereas maximum levels of
proteinuria were generally seen 5–7 days after illness onset
(Figure 1). As expected, patients with severe PUUV-induced AKI
had a longer duration of hospitalization, higher systolic and
diastolic blood pressures, more severe oliguria, and greater weight
change compared to those with non-severe PUUV-induced AKI
(Table 1).
Leukocytosis is a risk factor for severe PUUV-induced AKI
PUUV nephropathia epidemica is often characterized by a
moderate leukocytosis, thrombocytopenia, elevated C-reactive
protein (CRP) levels, and a mild transaminitis [11,12]. We found
that maximum white blood cell (WBC) counts were significantly
higher in PUUV-infected patients who developed severe AKI
compared to those with non-severe AKI (Table 2), and the highest
WBC levels were generally seen 3–6 days after illness onset
(Figure 1a). The maximum leukocyte count was positively
correlated with the peak fold-change in serum Cr, regardless of
AKI severity classification (Spearman r=0.54 [0.26–0.74],
p=0.001). By contrast, there were no significant associations
between PUUV-induced AKI severity and platelet counts, CRP
levels, or alanine aminotransferase (ALT) levels (Table 2).
Urine IL-6 and IL-8 levels are positively correlated with
AKI severity in PUUV nephropathia epidemica
In an earlier study, high plasma interleukin (IL)-6 levels were
found to be associated with clinically severe PUUV NE [6]. We
measured the serial daily urine and plasma concentrations of 8
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PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e35402cytokines and chemokines over the course of acute PUUV
infection (IL-1a, IL-1b, IL-2, IL-6, IL-8, IL-15, CXC Ligand 10
(CXCL10), and monocyte chemoattractant protein-1 (MCP-1)).
The maximum levels of IL-6 in urine and plasma during acute
illness were positively correlated with PUUV-induced AKI
severity. Maximum urine IL-8 concentrations, but not plasma
IL-8 concentrations, were also positively associated with PUUV-
induced AKI (Figures 2a–d). We did not find any significant
associations between the degree of PUUV-induced AKI and
urine or plasma levels of IL-1a, IL-1b, IL-2, IL-15, CXCL10, or
MCP-1. Urine cytokine associations did not differ whether the
levels were expressed as a concentration or fractional excretion.
Urinary sediment GATA-3 mRNA levels are positively
correlated with AKI severity in PUUV nephropathia
epidemica
In an attempt to characterize the local and renal-specific
immune responses in acute PUUV infections, we measured
mRNA expression levels of a T-cell associated gene (CD3e), a
type 1 cytokine transcription factor (T-bet), and a type 2 cytokine
Figure 1. The rise in serum creatinine (Cr) is higher in Puumala virus (PUUV)-infected patients with severe acute kidney injury (AKI)
compared to those with non-severe AKI. The maximum white blood cell (WBC) count occurred several days before the peak Cr in PUUV-infected
patients with severe AKI (a). PUUV-infected patients with severe AKI have greater proteinuria than those with non-severe AKI (b). Severe AKI is .3-
fold rise in serum Cr during acute illness compared to a 6 month baseline. Illness day 1 is the first calendar day of reported fever. Symbols and error
bars are mean6S.E.
doi:10.1371/journal.pone.0035402.g001
Table 1. Characteristics of study subjects with PUUV nephropathia epidemica.
Non-severe AKI
a (n=21) Severe AKI
a (n=15) Univariate p-value
Fold-change in serum creatinine
b (sCr) (peak sCr/baseline sCr) 1.7 (1.4, 2.0) 7.6 (5.4, 9.7) ---
Age (y)
b 45 (39, 50) 46 (40, 53) 1.0
Gender (M:F) 12:9 12:3 0.3
Number of days of illness at time of hospital admission
b 4 (4, 5) 5 (4, 5) 0.4
Duration of hospitalization (days) 5 (4, 6) 8 (6, 9) 0.001
Tobacco smokers (%) 38% 60% 0.3
BMI (kg/m
2)
b 23.3 (19.4, 27.2) 27.9 (25.8, 30.1) 0.08
Maximum systolic blood pressure
b (mm Hg) 134 (129, 140) 151 (140, 162) 0.02
Minimum systolic blood pressure
b (mm Hg) 111 (104, 117) 122 (112, 131) 0.04
Maximum diastolic blood pressure
b (mm Hg) 86 (81, 91) 93 (88, 99) 0.04
Minimum diastolic blood pressure
b (mm Hg) 68 (62, 73) 69 (64, 74) 0.7
Minimum urine output
b (ml/24 h) 1,521 (1,084, 1,959) 955 (577, 1,332) 0.049
Dweight
b(kg) 1.6 (1.1, 2.1) 4.2 (2.5, 5.8) ,0.001
aAKI=acute kidney injury; severe AKI=.3-fold rise in serum creatinine during acute illness compared to a 6 month baseline value.
bValues are median (95% confidence interval of median).
doi:10.1371/journal.pone.0035402.t001
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The levels of CD3e, T-bet, and GATA-3 mRNA in urinary cells
during acute illness were expressed relative to 2 week convalescent
values in each patient. Urinary sediment CD3e mRNA expression
levels were essentially unchanged throughout acute illness and
were not significantly different between patients with severe and
non-severe AKI (Figure 3a). In patients with severe AKI, urinary
sediment GATA-3 mRNA expression was increased, and T-bet
mRNA expression was decreased, during acute illness compared
to 2 week convalescent values (Figures 3b&c). Maximum urinary
sediment GATA-3 mRNA levels were significantly higher in
PUUV infected patients who developed severe AKI compared to
those with non-severe AKI. The maximum urinary sediment
GATA-3 mRNA level was positively correlated with the peak
fold-change in serum Cr, regardless of AKI severity classification
(Spearman’s r=0.53 [0.21–0.75], p=0.003).
Table 2. Clinical laboratory indicators in study subjects with PUUV nephropathia epidemica.
Non-severe AKI
a
(n=21) Severe AKI
a (n=15) Univariate p-value
Maximum leukocyte count
b (610
6/mm
3) 9.2 (8.1, 10.3) 13.4 (10.9, 15.9) 0.001
Minimum platelet count
b (610
3/mm
3) 58 (47, 69) 59 (42, 75) 0.9
Maximum C-reactive protein level
b (mg/L) 103 (80, 125) 91 (71, 111) 0.5
Maximum alanine aminotransferase (ALT) level
b (U/ml) 64 (40, 88) 58 (44, 71) 0.5
aAKI=acute kidney injury; severe AKI=.3-fold rise in serum creatinine during acute illness compared to a 6 month baseline value.
bValues are median (95% confidence interval of median).
doi:10.1371/journal.pone.0035402.t002
Figure 2. Maximum urine IL-6, plasma IL-6, and urine IL-8 concentrations are positively correlated with the degree of PUUV-
induced AKI. a) maximum urine IL-6 levels b) maximum plasma IL-6 levels c) maximum urine IL-8 levels d) maximum plasma IL-8 levels.
doi:10.1371/journal.pone.0035402.g002
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GATA-3 mRNA levels are independent risk factors for
severe AKI in PUUV nephropathia epidemica
On univariate analysis, maximum peripheral WBC, urine IL-8,
and urinary cell GATA3 mRNA levels were associated with severe
AKI in PUUV infections. In a multivariate logistic regression
model, maximum urinary cell GATA-3 mRNA levels were an
independent risk factor for severe AKI in PUUV nephropathia
epidemica. The maximum WBC trended significantly with
PUUV-induced severe AKI (Table 3). Among patients with severe
AKI, the maximum urinary cell GATA-3 mRNA level occurred 1
day [0–4 days] (median [95% CI]) before the maximum serum Cr
level, whereas the maximum WBC count occurred 2 days [0–4
days] (median [95% CI]) before the maximum serum Cr. In a
linear regression model, the log10 maximum WBC and log10
maximum urinary cell GATA-3 mRNA were significantly
correlated with the log10 transformed peak Cr ratio (Table 3).
Discussion
In this study, 36 patients presenting with PUUV infection were
prospectively followed throughout acute illness, and 2 weeks and 6
months after hospital discharge. During the course of their acute
PUUV infection, the patients developed either non-severe or
severe AKI as defined by serum Cr levels (severe AKI=.3 fold
rise in serum Cr during acute illness compared to 6 month baseline
value [10]). As expected, PUUV infected patients who developed
severe AKI had a longer duration of hospitalization, greater
changes in blood pressure, urine output, and weight than those
with non-severe AKI.
To assess potential risk factors for severe AKI in PUUV NE, we
first examined common clinical laboratory indicators. Nearly all
PUUV NE patients had elevated WBC counts, a decrease in
platelet counts, and increases in CRP and ALT levels during acute
illness. Only the maximum WBC count correlated with the
severity of AKI on univariate and multivariate analyses.
Leukocytosis likely reflects the renal inflammatory process during
PUUV infection. The maximum WBC count occurred 2 days [0–
4 days] (median [95% CI]) before the maximum serum Cr during
acute illness. Similar to previous reports, we found that CRP levels
did not correlate with the severity of PUUV induced AKI [12].
Serial levels of eight cytokines and chemokines (IL-1a, IL-1b,
IL-2, IL-6, IL-8, IL-15, CXCL10 and MCP-1) were measured
daily in both urine and plasma during acute PUUV NE. Only
Figure 3. Urinary sediment GATA-3 mRNA levels are elevated and T-bet mRNA levels are decreased during acute illness in PUUV-
induced severe AKI. Severe AKI is .3-fold rise in serum Cr during acute illness compared to a 6 month baseline. Illness day 1 is the first calendar
day of reported fever. a) Urinary sediment CD3e mRNA relative expression compared to 2 week baseline value b) Urinary sediment GATA-3 mRNA
relative expression compared to 2 week baseline value c) Urinary sediment T-bet mRNA relative expression compared to 2 week baseline value.
Symbols and error bars are mean6S.E.
doi:10.1371/journal.pone.0035402.g003
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levels, positively correlated with AKI severity in PUUV infected
patients. Serum and urine levels of IL-6 have been previously
reported to correspond with PUUV-induced AKI severity
[6,7,13]. The univariate correlation between maximum urine
IL-8 concentrations and PUUV-induced AKI severity is a novel
finding and suggests a local inflammatory reaction in PUUV
infected kidneys. Kidney biopsies of patients with PUUV NE
revealed histological evidence of local inflammation and increased
expression of several cytokines in the peritubular area of the distal
nephron [11]. However, none of the currently tested cytokines or
chemokines were independent risk factors for PUUV-induced AKI
severity on multivariate analysis.
In an attempt to characterize local and renal-specific immune
responses in acute PUUV infections, we next measured mRNA
expression levels of a T-cell receptor associated gene (CD3e), a
type 1 cytokine transcription factor (T-bet), and a type 2 cytokine
transcription factor (GATA-3) in serial urinary sediment samples.
Only maximum GATA-3 mRNA levels in urinary sediment
correlated with the severity of AKI on univariate and multivariate
analyses. The maximum urinary sediment GATA-3 mRNA level
occurred 1 day [0–4 days] (median [95% CI]) before the
maximum serum Cr during acute illness. GATA-3 is a necessary
transcription factor for the generation of type 2 T-cells [9,14], and
severe AKI in PUUV infection might be due to excessive type 2 T-
cell responses compared to type 1 T-cells in the kidney. Excessive
type 1 T-cell kidney infiltration and T-bet urinary sediment levels
have been implicated in lupus nephritis [15], proliferative and
crescentic glomerulonephritis [16], and acute kidney transplant
rejection [17]. Elevated GATA-3 mRNA levels in circulating
mononuclear cells have been reported in patients with minimal
change nephrotic syndrome [18]. In addition to type 2 T-cells, the
GATA-3 transcription factor is expressed in human kidney
embryogenesis [19], and by distal renal tubular and collecting
duct cells in the adult kidney [20]. The T-cell receptor associated
gene (CD3e) urinary sediment mRNA level was essentially
unchanged throughout acute illness, and there was no difference
between patients with severe and non-severe AKI due to PUUV
infections. Therefore, we postulate that the sources of elevated
GATA-3 mRNA levels in the urinary sediment of patients with
severe PUUV-induced AKI were distal renal tubular or collecting
duct cells. Another possibility is that the cellular sources of GATA-
3 mRNA in the urinary sediment changed over time. In our study
protocol, we were unable to definitively identify the cellular
sources of GATA-3 mRNA expression in urinary sediment. We
suspect that elevated GATA-3 mRNA urinary sediment levels in
patients with severe AKI reflect kidney injury in distal tubular or
collecting duct cells in PUUV-infected kidneys. Additional studies
and patients are required to identify whether the urinary sediment
GATA-3 mRNA levels in PUUV infection reflect type 2 T-cell
responses or distal tubular kidney injury.
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